Riddhi Siddhi Gluco Biols Intrinsic Value
RIDDHI Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹926.40 | ₹741.12 - ₹1111.68 | +99.8% | EPS: ₹77.20, Sector P/E: 12x |
| Book Value Method | asset | ₹1159.38 | ₹1043.44 - ₹1275.32 | +150.0% | Book Value/Share: ₹2267.14, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹246.86 | ₹222.17 - ₹271.55 | -46.8% | Revenue/Share: ₹308.57, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹754.29 | ₹678.86 - ₹829.72 | +62.7% | EBITDA: ₹88.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹185.50 | ₹148.40 - ₹222.60 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹494.08 | ₹444.67 - ₹543.49 | +6.5% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹636.13 | ₹572.52 - ₹699.74 | +37.2% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹1391.25 | ₹1252.12 - ₹1530.38 | +200.0% | EPS: ₹77.20, BVPS: ₹2267.14 |
Want to compare with current market value? Check RIDDHI share price latest .
Valuation Comparison Chart
RIDDHI Intrinsic Value Analysis
What is the intrinsic value of RIDDHI?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Riddhi Siddhi Gluco Biols (RIDDHI) is ₹754.29 (median value). With the current market price of ₹463.75, this represents a +62.7% variance from our estimated fair value.
The valuation range spans from ₹185.50 to ₹1391.25, indicating ₹185.50 - ₹1391.25.
Is RIDDHI undervalued or overvalued?
Based on our multi-method analysis, Riddhi Siddhi Gluco Biols (RIDDHI) appears to be trading below calculated value by approximately 62.7%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 38.12 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Asset Turnover Ratio | 0.12x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Riddhi Siddhi Gluco Biols
Additional stock information and data for RIDDHI
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-28 Cr | ₹-28 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹9 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹161 Cr | ₹126 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹130 Cr | ₹104 Cr | Positive Free Cash Flow | 8/10 |